Goldman Sachs Group Inc 10x Genomics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 461,232 shares of TXG stock, worth $6.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
461,232
Previous 255,363 80.62%
Holding current value
$6.14 Million
Previous $4.97 Million 109.71%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$15.71 - $23.49 $3.23 Million - $4.84 Million
205,869 Added 80.62%
461,232 $10.4 Million
Q2 2024

Aug 13, 2024
SELL
$19.45 - $37.37 $598,729 - $1.15 Million
-30,783 Reduced 10.76%
255,363 $4.97 Million
Q1 2024

May 15, 2024
SELL
$36.08 - $54.3 $3.13 Million - $4.71 Million
-86,727 Reduced 23.26%
286,146 $10.7 Million
Q4 2023

Feb 13, 2024
BUY
$34.32 - $57.55 $62,290 - $104,453
1,815 Added 0.49%
372,873 $20.9 Million
Q3 2023

May 14, 2024
SELL
$40.86 - $62.98 $74,160 - $114,308
-1,815 Reduced 0.49%
371,058 $15.3 Million
Q3 2023

Nov 14, 2023
SELL
$40.86 - $62.98 $12.2 Million - $18.7 Million
-297,471 Reduced 44.5%
371,058 $15.3 Million
Q2 2023

May 14, 2024
BUY
$50.96 - $58.72 $14.4 Million - $16.6 Million
283,432 Added 73.6%
668,529 $37.3 Million
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $14.4 Million - $16.6 Million
283,432 Added 73.6%
668,529 $37.3 Million
Q1 2023

May 14, 2024
SELL
$35.33 - $55.79 $1.14 Million - $1.8 Million
-32,196 Reduced 7.72%
385,097 $21.5 Million
Q1 2023

May 11, 2023
SELL
$35.33 - $55.79 $1.14 Million - $1.8 Million
-32,196 Reduced 7.72%
385,097 $21.5 Million
Q4 2022

May 14, 2024
SELL
$24.4 - $41.3 $2.4 Million - $4.06 Million
-98,393 Reduced 19.08%
417,293 $15.2 Million
Q4 2022

Feb 13, 2023
SELL
$24.4 - $41.3 $2.4 Million - $4.06 Million
-98,393 Reduced 19.08%
417,293 $15.2 Million
Q3 2022

May 14, 2024
SELL
$28.48 - $52.59 $3.58 Million - $6.61 Million
-125,732 Reduced 19.6%
515,686 $14.7 Million
Q3 2022

Nov 10, 2022
SELL
$28.48 - $52.59 $3.58 Million - $6.61 Million
-125,732 Reduced 19.6%
515,686 $14.7 Million
Q2 2022

May 14, 2024
BUY
$36.95 - $82.41 $9.92 Million - $22.1 Million
268,545 Added 72.02%
641,418 $29 Million
Q2 2022

Aug 15, 2022
SELL
$36.95 - $82.41 $1.66 Million - $3.7 Million
-44,852 Reduced 6.54%
641,418 $29 Million
Q1 2022

May 16, 2022
BUY
$55.7 - $145.79 $27.1 Million - $70.9 Million
485,997 Added 242.67%
686,270 $52.2 Million
Q4 2021

Feb 14, 2022
SELL
$135.05 - $182.59 $2.51 Million - $3.39 Million
-18,589 Reduced 8.49%
200,273 $29.8 Million
Q3 2021

Nov 10, 2021
BUY
$145.58 - $192.14 $31.9 Million - $42.1 Million
218,862 New
218,862 $31.9 Million

Others Institutions Holding TXG

# of Institutions
290
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email